Abstract
Percutaneous chemonucleolysis with condoliase has been available for painful lumbar disc herniation since 2018 in Japan. This study investigated clinical and radiographic outcomes three months after the administration because the secondary surgical removal is most required during this period for the insufficient pain relief, and analyzed whether the differences of intradiscal injection areas affected the clinical outcomes. We retrospectively investigated 47 consecutive patients (males, 31; median age, 40 years) three months after the administration. Clinical outcomes were evaluated using the Japanese Orthopaedic Association Back Pain Questionnaire (JOABPEQ), a visual analog scale (VAS) score for low back pain, and VAS scores for pains and numbness in the lower limbs. Radiographic outcomes were analyzed in 41 patients, using parameters such as mid-sagittal disc height and maximal protrusion length of herniation on MRI preoperatively and at the final follow-up. Postoperative median evaluation period was 90 days. The effective rate of low back pain based on the pain-related disorders at baseline and the last follow-up in the JOABPEQ reached 79.5%. The postoperative proportion of VAS scores recovery ≥ 2 points and ≥ 50% for pains in the lower limbs were 80.9% and 66.0%, respectively, revealing satisfactory effectiveness. Preoperative median mid-sagittal disc height significantly reduced from 9.5 to 7.6 mm postoperatively. There were no significant differences in pain relief in the lower limbs by injection areas in the center and the dorsal 1/3rd near the herniation of nucleus pulposus. Chemonucleolysis with condoliase revealed satisfactory short-term outcomes after the administration regardless of intradiscal injection areas.
Similar content being viewed by others
Data availability
Not applicable.
References
Banno T, Hasegawa T, Yamato Y et al (2021) Clinical outcome of condoliase injection treatment for lumbar disc herniation: Indications for condoliase therapy. J Orthop Sci 26:79–85. https://doi.org/10.1016/j.jos.2020.02.002
Banno T, Hasegawa T, Yamato Y et al (2022) Disc degeneration could be recovered after chemonucleolysis with condoliase. -1 year clinical outcome of condoliase therapy. J Orthop Sci 27:767–773. https://doi.org/10.1016/j.jos.2021.05.005
Chiba K, Matsuyama Y, Seo T, Toyama Y (2018) Condoliase for the Treatment of Lumbar Disc Herniation: A Randomized Controlled Trial. Spine (Phila Pa 1976) 43:E869–E876. https://doi.org/10.1097/BRS.0000000000002528
Dworkin RH, Turk DC, Wyrwich KW et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9:105–121. https://doi.org/10.1016/j.jpain.2007.09.005
Fukui M, Chiba K, Kawakami M et al (2009) JOA Back Pain Evaluation Questionnaire (JOABPEQ)/JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ). The report on the development of revised versions. April 16, 2007. The Subcommittee of the Clinical Outcome Committee of the Japanese Orthopaedic Association on Low Back Pain and Cervical Myelopathy Evaluation. J Orthop Sci 14:348–365. https://doi.org/10.1007/s00776-009-1337-8
Hirai T, Takahashi T, Tanaka T et al (2021) Intradiscal Injection with Condoliase (Chondroitin Sulfate ABC Endolyase) for Painful Radiculopathy Caused by Lumbar Disc Herniation. Spine Surg Relat Res 6:252–260. https://doi.org/10.22603/ssrr.2021-0151
Inoue M, Sainoh T, Kojima A et al (2021) Efficacy and Safety of Condoliase Disc Administration as a New Treatment for Lumbar Disc Herniation. Spine Surg Relat Res 6:31–37. https://doi.org/10.22603/ssrr.2021-0035
Iwabuchi M, Kikuchi S, Sato K (2004) Anatomic and clinical investigation of a low signal peripheral line around the lumbar herniated nucleus pulposus (black line) on magnetic resonance imaging. Fukushima J Med Sci 50:11–19. https://doi.org/10.5387/fms.50.11
Kato F, Mimatsu K, Iwata H, Miura T (1993) Comparison of tissue reaction with chondroitinase ABC and chymopapain in rabbits as the basis of clinical application in chemonucleolysis. Clin Orthop Relat Res 288:294–302
Macnab I, McCulloch JA, Weiner DS, Hugo EP, Galway RD, Dall D (1971) Chemonucleolysis. Can J Surg 14:280–289
McGirt MJ, Eustacchio S, Varga P et al (2009) A prospective cohort study of close interval computed tomography and magnetic resonance imaging after primary lumbar discectomy: factors associated with recurrent disc herniation and disc height loss. Spine 34:2044–2051. https://doi.org/10.1097/BRS.0b013e3181b34a9a
Nakajima H, Kubota A, Maezawa Y et al (2020) Short-Term Outcome and Predictors of Therapeutic Effects of Intradiscal Condoliase Injection for Patients with Lumbar Disc Herniation. Spine Surg Relat Res 5:264–271. https://doi.org/10.22603/ssrr.2020-0126
Okada E, Suzuki S, Nori S et al (2021) The effectiveness of chemonucleolysis with condoliase for treatment of painful lumbar disc herniation. J Orthop Sci 26:548–554. https://doi.org/10.1016/j.jos.2020.06.004
Olmarker K, Danielsen N, Nordborg C, Rydevik B (1991) Effects of chondroitinase ABC on intrathecal and peripheral nerve tissue. An in vivo experimental study on rabbits. Spine (Phila Pa 1976) 16:43–45. https://doi.org/10.1097/00007632-199101000-00008
Olmarker K, Strömberg J, Blomquist J et al (1996) Chondroitinase ABC (pharmaceutical grade) for chemonucleolysis. Functional and structural evaluation after local application on intraspinal nerve structures and blood vessels. Spine (Phila Pa 1976) 21:1952–1956. https://doi.org/10.1097/00007632-199609010-00002
Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N (2001) Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976) 26:1873–1878. https://doi.org/10.1097/00007632-200109010-00011
Wardlaw D (2016) Sciatica caused by disc herniation: Why is Chymopapain Chemonucleolysis denied to our patients? Int J Spine Surg 10:44. https://doi.org/10.14444/3044
Yamagata T, Saito H, Habuchi O, Suzuki S (1968) Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem 243:1523–1535
Acknowledgements
We are grateful to the radiologists of my hospital for their prompt preoperative radiological examinations and image processing work. The authors would like to thank FORTE for the English language review.
Author information
Authors and Affiliations
Contributions
The study conception and design were proposed by Tatsuya Ohtonari. Data collection was performed by Tatsuya Ohtonari, Rina Torii, Shohei Noguchi, Takehiro Kitagawa and Nobuharu Nishihara. Formal analysis was performed by Tatsuya Ohtonari, Rina Torii and Shohei Noguchi. The first draft of the manuscript was written by Tatsuya Ohtonari and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval and Consent to participate
This retrospective study was approved by the institutional review board at the Brain Attack Center, Ota Memorial Hospital (registration No: 230). Since this was a retrospective study, the requirement for written informed consent from patients was waived.
Human and animal ethics
This retrospective study was performed in accordance with the Declaration of Helsinki.
Consent for publication
This manuscript contains no individual person’s data in any form.
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Portions of this work were presented in the symposium at the 81st Annual Meeting of the Japan Neurosurgical Society, September 30, 2022, Yokohama, Japan.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ohtonari, T., Torii, R., Noguchi, S. et al. Short-term clinical and radiographic outcomes of chemonucleolysis with condoliase for painful lumbar disc herniation and analysis regarding intradiscal injection area. Neurosurg Rev 46, 59 (2023). https://doi.org/10.1007/s10143-023-01966-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10143-023-01966-w